Akash Patnaik, MD, PhD, MMSc (@akashpatnaik7) 's Twitter Profile
Akash Patnaik, MD, PhD, MMSc

@akashpatnaik7

Medical Oncologist/Physician-Scientist passionate about translational research, cancer medicine and international travel.

ID: 791333854057345024

linkhttps://voices.uchicago.edu/patnaiklab/ calendar_today26-10-2016 17:41:07

194 Tweet

383 Followers

121 Following

Akash Patnaik, MD, PhD, MMSc (@akashpatnaik7) 's Twitter Profile Photo

Congrats to the TRITON2 team on yet another recent publication reporting the final results of the Phase 2 study which led to the FDA approval of rucaparib in mCRPC! We learned a lot, and it has been an honor to be part of this effort! Clovis Oncology doi.org/10.1016/j.euru…

Akash Patnaik, MD, PhD, MMSc (@akashpatnaik7) 's Twitter Profile Photo

Lovely to see old friends and colleagues & present our work on innate immune activation in prostate cancer at my favorite Coffey-Holden #PCFAcademy brainstorm meeting! Thanks to PCF Science and organizing committee for a fantastic meeting that will move the field forward!

University of Chicago Hem/Onc Fellows (@uchemoncfellows) 's Twitter Profile Photo

And finally but most importantly a very warm welcome to our fantastic new first year fellows!! We’re so excited to have you with us and can’t wait to see how you’ll grow in this transformative year! Faith Abodunrin MD @SamuelJYates Dan Peiffer Margarite Matossian, MD PhD University of Chicago Hematology/Oncology

And finally but most importantly a very warm welcome to our fantastic new first year fellows!! We’re so excited to have you with us and can’t wait to see how you’ll grow in this transformative year! <a href="/your_hemoncdoc/">Faith Abodunrin MD</a> @SamuelJYates <a href="/theproffermd/">Dan Peiffer</a> <a href="/MargariteMatos1/">Margarite Matossian, MD PhD</a> <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a>
Akash Patnaik, MD, PhD, MMSc (@akashpatnaik7) 's Twitter Profile Photo

We are hiring for open Lab Manager and postdoctoral research fellowship positions! If you are passionate about tumor immunology, novel immunotherapeutics and/or prostate cancer translational research, please reach out or circulate. Thanks! voices.uchicago.edu/patnaiklab/

Akash Patnaik, MD, PhD, MMSc (@akashpatnaik7) 's Twitter Profile Photo

Thrilled to share our paper demonstrating an immunometabolic therapeutic strategy that results in complete and durable tumor control in PTEN/p53-deficient aggressive-variant prostate cancers! Clinical Cancer Research Prostate Cancer Foundation PCF Science University of Chicago Hematology/Oncology UChicago Medicine doi.org/10.1158/1078-0…

Akash Patnaik, MD, PhD, MMSc (@akashpatnaik7) 's Twitter Profile Photo

Thrilled to share our paper demonstrating an immunometabolic therapeutic strategy that results in complete/durable tumor control in PTEN/p53-deficient aggressive-variant prostate cancers! kiranj chaudagar Clinical Cancer Research Prostate Cancer Foundation @PCF_Science@UChicagoHemOnc doi.org/10.1158/1078-0…

Akash Patnaik, MD, PhD, MMSc (@akashpatnaik7) 's Twitter Profile Photo

Thrilled to share our story demonstrating NLRP3 infammasome as an androgen receptor (AR)-regulated phagocytic checkpoint within tumor-associated macrophages (TAM), which drives TAM-mediated tumor clearance upon priming with AR blockade and NLRP3 agonism: biorxiv.org/content/10.110…

Sasha Gusev (@sashagusevposts) 's Twitter Profile Photo

Not only has the NIH supported the most important drugs and treatments to date, the modern era of genomically driven drug discovery justifies greatly *increasing* the NIH budget. There are thousands of targets with known associatons in humans simply waiting to be characterized.

American Cancer Society Cancer Action Network (@acscan) 's Twitter Profile Photo

Today the House passed the Full-Year Continuing Appropriations & Extensions Act. It contains no increases for federal #CancerResearch or prevention funding & significant cuts to Congressionally Directed Medical Research Programs (CDMRP): fightcancer.org/releases/us-ho… (1/3)

Today the House passed the Full-Year Continuing Appropriations &amp; Extensions Act. It contains no increases for federal #CancerResearch or prevention funding &amp; significant cuts to Congressionally Directed Medical Research Programs (CDMRP): fightcancer.org/releases/us-ho… (1/3)